动脉粥样硬化及其相关心血管疾病药物治疗新靶点的研究进展  

Research progress on the drug therapeutic target of atherosclerosis and its related cardiovascular diseases

作　　者：郑刚[1] 

机构地区：[1]天津市第三中心医院分院心内科,天津300250

出　　处：《世界临床药物》2018年第1期54-58,共5页World Clinical Drug

摘　　要：动脉粥样硬化是冠心病、脑卒中及外周血管病的主要原因。动脉粥样硬化是多因素共同作用引起的,其发病机制尚未完全阐明。药物治疗是动脉粥样硬化及其相关心血管疾病的主要治疗手段之一,发现与动脉粥样硬化相关的靶点是药物治疗的关键。本文主要综述近年发现的与动脉粥样硬化及其相关心血管疾病发病相关的治疗新靶点。Atherosclerosis is the main cause of coronary heart disease, stroke and peripheral vascular disease. Its pathogenesis is complex and has not been fully elucidated at present. The drug therapy is one of the main treatments for atherosclerosis and its related cardiovascular diseases. The key to drug therapy is to discover the targets associated with atherosclerosis. This review summarizes the updated research progress on the targets of atherosclerosis and its related cardiovascular diseases.

关 键 词：动脉粥样硬化 动脉粥样硬化性心血管疾病 药物治疗 

分 类 号：R541.4[医药卫生—心血管疾病] R972.6[医药卫生—内科学]